An in‐depth understanding of the processes that modulate MAM structures and regulate BACE1‐ or γ‐secretase‐mediated processing of APP or palAPP for Aβ generation, specifically in the axons, could significantly impact the development of early therapies for AD. Here, BACE1 is linked to Alzheimer disease.